Europe Needs a Central, Transparent, and Evidence-Based Approval Process for Behavioural Prevention Interventions
article has not abstract
Vyšlo v časopise:
Europe Needs a Central, Transparent, and Evidence-Based Approval Process for Behavioural Prevention Interventions. PLoS Med 11(10): e32767. doi:10.1371/journal.pmed.1001740
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001740
Souhrn
article has not abstract
Zdroje
1. Institute for Health Metrics and Evaluation (2013) GBD Compare. Available: http://viz.healthmetricsandevaluation.org/gbd-compare/. Accessed 4 March 2014.
2. BeagleholeR, BonitaR, HortonR, AdamsC, AlleyneG, et al. (2011) Priority actions for the non-communicable disease crisis. Lancet 377: 1438–1447 Available: http://www.ncbi.nlm.nih.gov/pubmed/21474174. Accessed 12 March 2012
3. WHO Europe (2006) Gaining Health The European Strategy for the Prevention and Control of Noncommunicable Diseases. Copenhagen, Denmark: WHO Regional Office for Europe.
4. BeagleholeR, BonitaR, AlleyneG, HortonR, LiL, et al. (2011) UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet 378: 449–455 Available: http://www.ncbi.nlm.nih.gov/pubmed/21665266. Accessed 12 March 2012
5. EMCDDA (2013) European Drug Report. Luxembourg: Publications Office of the European Union. Available: http://www.emcdda.europa.eu/attachements.cfm/att_213154_EN_TDAT13001ENN1.pdf. Accessed 4 March 2014.
6. WHO Regional Office for Europe (2012) Health 2020: a European policy framework supporting action across government and society for health and well-being. Copenhagen, Denmark: WHO Regional Office for Europe.
7. WieselerB, McGauranN, KaiserT (2012) We need access to data on all clinical trials, not just some. BMJ 345: e8001 Available: http://www.ncbi.nlm.nih.gov/pubmed/23183067. Accessed 26 June 2014
8. WerchCE, OwenDM (2002) Iatrogenic effects of alcohol and drug prevention programs. J Stud Alcohol 63: 581–590 Available: http://www.ncbi.nlm.nih.gov/pubmed/12380855. Accessed 16 July 2012
9. KirbyD, KorpiM, BarthRP, CagampangHH (1997) The impact of the Postponing Sexual Involvement curriculum among youths in California. Fam Plann Perspect 29: 100–108 Available: http://www.ncbi.nlm.nih.gov/pubmed/9179578. Accessed 3 June 2012
10. Petrosino A, Turpin Petrosino C, John B (2004) “Scared Straight” and Other Juvenile Awareness Programs for Preventing Juvenile Delinquency. Campbell Syst Rev 2004.2. doi:10.4073/csr.2004.2.
11. SallisJF, McKenzieTL, AlcarazJE, KolodyB, HovellMF, et al. (1993) Project SPARK. Effects of physical education on adiposity in children. Ann N Y Acad Sci 699: 127–136 Available: http://www.ncbi.nlm.nih.gov/pubmed/8267303. Accessed 2 July 2012
12. SlobodaZ, StephensRC, StephensPC, GreySF, TeasdaleB, et al. (2009) The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program. Drug Alcohol Depend 102: 1–10 Available: http://www.ncbi.nlm.nih.gov/pubmed/19332365. Accessed 19 April 2012
13. SackettDL (2002) The arrogance of preventive medicine. CMAJ 167: 363–364 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=117852&tool=pmcentrez&rendertype=abstract. Accessed 13 June 2012
14. Faggiano F, Vigna-Taglianti FD, Versino E, Zambon A, Borraccino A, et al.. (2005) School-based prevention for illicit drugs' use. Cochrane Database Syst Rev: CD003020. Available: http://www.ncbi.nlm.nih.gov/pubmed/15846647. Accessed 11 November 2013.
15. Foxcroft DR, Tsertsvadze A (2011) Universal multi-component prevention programs for alcohol misuse in young people. Cochrane Database Syst Rev: CD009307. Available: http://www.ncbi.nlm.nih.gov/pubmed/21901732. Accessed 11 November 2013.
16. Waters E, de Silva-Sanigorski A, Hall BJ, Brown T, Campbell KJ, et al.. (2011) Interventions for preventing obesity in children. Cochrane database Syst Rev: CD001871. Available: http://www.ncbi.nlm.nih.gov/pubmed/22161367. Accessed 11 November 2013.
17. MichieS, van StralenMM, WestR (2011) The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 6: 42 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3096582&tool=pmcentrez&rendertype=abstract. Accessed 11 November 2013
18. NoarSM, ZimmermanRS (2005) Health Behavior Theory and cumulative knowledge regarding health behaviors: are we moving in the right direction? Health Educ Res 20: 275–290 Available: http://www.ncbi.nlm.nih.gov/pubmed/15632099. Accessed 26 July 2011
19. MichieS, FixsenD, GrimshawJM, EcclesMP (2009) Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implement Sci 4: 40 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2717906&tool=pmcentrez&rendertype=abstract. Accessed 11 November 2013
20. HansenWB, DusenburyL, BishopD, DerzonJH (2007) Substance abuse prevention program content: systematizing the classification of what programs target for change. Health Educ Res 22: 351–360 Available: http://www.ncbi.nlm.nih.gov/pubmed/16963725. Accessed 31 August 2011
21. RileyBL, MacDonaldJ, MansiO, KothariA, KurtzD, et al. (2008) Is reporting on interventions a weak link in understanding how and why they work? A preliminary exploration using community heart health exemplars. Implement Sci 3: 27 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2413262&tool=pmcentrez&rendertype=abstract. Accessed 11 November 2013
22. GandhiAG, Murphy-GrahamE, PetrosinoA, ChrismerSS, WeissCH (2007) The devil is in the details: examining the evidence for “proven” school-based drug abuse prevention programs. Eval Rev 31: 43–74 Available: http://www.ncbi.nlm.nih.gov/pubmed/17259575. Accessed 26 June 2012
23. Bo A, Allara E, Ferri M (2011) Scientific evidence and practice: bridging the gap. A European Monitoring Center for Drugs and Drug Addiction (EMCDDA) project to promote Best Practice in Drug Addiction field. 19th Cochrane Colloquium; 20 October 2011; Madrid, Spain. Available: http://2011.colloquium.cochrane.org/abstracts/a1o4-scientific-evidence-and-practice-bridging-gap-european-monitoring-center-drugs-and-dr. Accessed 8 September 2014.
24. BrugJ, van DaleD, LantingL, KremersS, VeenhofC, et al. (2010) Towards evidence-based, quality-controlled health promotion: the Dutch recognition system for health promotion interventions. Health Educ Res 25: 1100–1106 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2974836&tool=pmcentrez&rendertype=abstract. Accessed 23 March 2012
25. Pharmaceutical Research and Manufacturers of America (n.d.) Drug Discovery And Development. Available: http://www.phrma.org/sites/default/files/pdf/PhRMA%20Profile%202013.pdf. Accessed 4 August 2011.
26. LipskyMS, SharpLK (2001) From idea to market: the drug approval process. J Am Board Fam Pract 14: 362–367 Available: http://www.ncbi.nlm.nih.gov/pubmed/11572541. Accessed 21 July 2011
27. CampbellM, FitzpatrickR, HainesA, KinmonthAL, SandercockP, et al. (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321: 694–696 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1118564&tool=pmcentrez&rendertype=abstract. Accessed 17 July 2012
28. CraigP, DieppeP, MacintyreS, MichieS, NazarethI, et al. (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337: a1655–a1655 Available: http://www.bmj.com/cgi/doi/10.1136/bmj.a1655. Accessed 15 March 2012
29. CollinsLM, Murphy Sa, NairVN, StrecherVJ (2005) A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med 30: 65–73 Available: http://www.ncbi.nlm.nih.gov/pubmed/16097907
30. CollinsLM, BakerTB, MermelsteinRJ, PiperME, JorenbyDE, et al. (2011) The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med 41: 208–226 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3053423&tool=pmcentrez&rendertype=abstract. Accessed 11 November 2013
31. Henry Rossi P, Lipsey MW, Freeman HE (2004) Evaluation: a systematic approach. New York: SAGE.
32. International Agency for Research on Cancer (2008) IARC Handbooks of Cancer Prevention in Tobacco Control. Volume 12. Lyon. Available: http://www.iarc.fr/en/publications/pdfs-online/prev/handbook14/handbook14.pdf.
33. Diego Concina (2012) An overview of Cochrane Systematic Reviews on NCD prevention - preliminary results [Thesis]. Alessandria, Italy: Università del Piemonte Orientale Amedeo Avogadro.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 10
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
- Developmental Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies
- Maternal Clinical Diagnoses and Hospital Variation in the Risk of Cesarean Delivery: Analyses of a National US Hospital Discharge Database
- Association of Medical Students' Reports of Interactions with the Pharmaceutical and Medical Device Industries and Medical School Policies and Characteristics: A Cross-Sectional Study